AEON Biopharma, Inc.·4

May 16, 4:17 PM ET

Bancroft Robert E. 4

4 · AEON Biopharma, Inc. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-14
Bancroft Robert E.
DirectorPRESIDENT & CEO
Transactions
  • Award

    Class A Common Stock

    2025-05-14+177,103177,103 total
Footnotes (1)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Class A Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on each anniversary of April 29, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary